资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Author Correction: Targeting CLDN182 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer

Sci Rep.. 2019; 
Zhu G1, Foletti D2,3, Liu X2, Ding S2,4, Melton Witt J2,5, Hasa-Moreno A2,6, Rickert M2,7, Holz C2,5, Aschenbrenner L8,9, Yang AH8, Kraynov E10, Evering W8, Obert L11,12, Lee C2,13, Sai T2, Mistry T2, Lindquist KC2, Van Blarcom T2,14, Strop P2,15, Chaparro-Riggers J2, Liu SH2,16.
Products/Services Used Details Operation
Stable Cell Line Development Services  Cell lines were engineered to express hCLDN18.2 or hCDLN18.2-Luciferase using pLVX-EF1a-Puro-P2A or pLVX-EF1a-Luc2-P2A lentivirus (GenScript). Get A Quote

摘要

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

关键词

Article Link >